Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer

JAMA Oncol. 2023 Mar 1;9(3):435-436. doi: 10.1001/jamaoncol.2022.7358.

Authors

Michele Reni¹, Marina Macchini¹, Luca Porcu²

Affiliations

¹ Pancreas Translational and Clinical Research Center, Department of Medical Oncology, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.
² Methodology for Clinical Research Laboratory, Oncology Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

PMID: 36701148
DOI: 10.1001/jamaoncol.2022.7358

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Fluorouracil / therapeutic use
Humans
Leucovorin / therapeutic use
Pancreatic Neoplasms* / drug therapy

Substances

Fluorouracil
Leucovorin